All News
Filter News
Found 808,991 articles
-
Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials for Nyxol® Eye Drops
9/4/2019
Ocuphire Pharma, Inc. announced that it has successfully enrolled 39 glaucoma patients in ORION-1 at 5 U.S. sites from late May to August 2019.
-
Bayer Awards $500,000 Grant To The St. Louis Magic House For New STEM Interactive Children's Exhibit
9/4/2019
Bayer has awarded The Magic House® St. Louis Children's Museum a $500,000 grant to create the Bayer STEM Pathway, a hands-on, interactive exhibit that will be designed to spark a life-long interest in STEM – Science, Technology, Engineering and Mathematics, in the young people who visit the not-for-profit museum.
-
North Texas Innovator Tapped as Catalyst Chief Medical Officer
9/4/2019
Jeffery Bullard, MD, a trailblazing physician and health care entrepreneur and innovator, has been named the new Chief Medical Officer for the Catalyst Health Network.
-
Epizyme Announces Board of Director Appointments to Support Continued Evolution and Growth
9/4/2019
Epizyme, Inc. announced the appointments of experienced commercial executive, Grant Bogle, and research and development executive, Victoria Richon, Ph.D., to the company’s board of directors.
-
Feinstein Institutes researchers place among top 1 percent of all cited scientists
9/4/2019
Finding demonstrates impact, reach of groundbreaking medical research at Northwell Health
-
Natera to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
9/4/2019
Natera, Inc. announced it will webcast a live presentation at the Morgan Stanley 17th Annual Global Healthcare Conference at the Grand Hyatt New York on Wednesday, Sept. 11, 2019, at 8:40 a.m. PT.
-
Bolt Biotherapeutics Appoints Veteran Executive Randall Schatzman as CEO to Lead the Next Phase of Growth
9/4/2019
Immune-stimulating Antibody Conjugate (ISAC) Immunotherapy Technology Attracts Seasoned Biotech Business Leader
-
Alexion to Present at the 17th Annual Morgan Stanley Global Healthcare Conference
9/4/2019
Alexion Pharmaceuticals announced that management will present at the 17th Annual Morgan Stanley Global Healthcare Conference in New York, NY on Monday, September 9th, 2019 at 8:45 a.m. ET.
-
The Prostate Cancer Foundation Made History By Lighting U.S. Landmarks "Blue" Across All 50 States To Illuminate Prostate Cancer Issue
9/4/2019
The World's Leading Prostate Cancer Research Non-profit Organization Encourages Americans to "Light It Blue" to Help Raise Prostate Cancer Awareness and Launches New Health, Nutrition & Wellness Cancer Prevention Guide for Prostate Cancer Awareness Month
-
Palliare, Dedicated to Making Operating Rooms Safer, Awarded European Patent
9/4/2019
EVA15 insufflator submission for FDA clearance planned for October 2019
-
Viriom Wins Grant Award to Establish Affiliate in Mainland China
9/4/2019
Viriom Inc., has won a grant award in the city of Shaoxing, Zhejiang province, to establish its affiliate in Mainland China.
-
DURECT to Present at the 21st Annual Rodman and Renshaw Global Investment Conference Sponsored by H.C. Wainwright
9/4/2019
DURECT Corporation announced that James E. Brown, Chief Executive Officer will be presenting at the 21st Annual Global Rodman and Renshaw Investment Conference, sponsored by H. C. Wainwright, at the Lotte New York Palace Hotel in New York on Monday, September 9, 2019 at 11:40 a.m. EDT.
-
Sight Sciences Raises $56M of Growth Capital to Lead the Development of the Standalone MIGS Market and Procedure-Based Dry Eye Market
9/4/2019
KCK Medical Technologies Group Leads the Company's Series D Equity Financing
-
Supply Clinic Unveils Expanded Seller Lineup
9/4/2019
Supply Clinic, the fastest-growing marketplace for dental supplies, announced the addition of several new distributors and manufacturers to its online platform.
-
Insulet Announces Pricing of Convertible Senior Notes Due 2026
9/4/2019
Insulet Corporation, a leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, has priced a private placement of $700 million aggregate principal amount of convertible senior notes due 2026.
-
Tekni-Plex purchases Canadian automation solutions manufacturer MMC Packaging
9/4/2019
Tekni-Plex has purchased automation equipment solutions manufacturer MMC Packaging Equipment Ltd.
-
Research Foundation to Cure Aids (RFTCA) Accelerates a Global Cure for Aids With License of Chromocell's Proprietary Cell Engineering Technology
9/4/2019
Research Foundation to Cure AIDS (RFTCA) has obtained a worldwide license to biotechnology known as Chromovert® Technology, to research, develop and commercialize a cure for HIV/AIDS.
-
J.D. Power Ranks Humana Highest In Mail Order Pharmacy Segment of Customer Satisfaction Study, Two Years in a Row
9/4/2019
Humana Pharmacy, a division of Humana Inc., has been named the top U.S. Mail Order Pharmacy in customer satisfaction in the J.D. Power 2019 U.S. Pharmacy Study, two years in a row.
-
Synlogic Presents Data from Phase 1/2a Study of SYNB1618 at the Annual Symposium of the Society for the Study of Inborn Errors of Metabolism (SSIEM)
9/4/2019
Synlogic, Inc. announced presentation of the full clinical data set from healthy volunteers and patient cohorts of a randomized, double-blind, placebo-controlled Phase 1/2a study of SYNB1618, which is being developed as an oral therapy for the treatment of phenylketonuria.
-
Devonian Health Group Announces the Formation of a Clinical Dermatology Advisory Board With Mandate to Assist in the Development of Cannabinoids-Based Pharmaceutical Products.
9/4/2019
Devonian Health Group Inc. announced that it has formed a Clinical Dermatology Advisory Board comprised of Canadian Key Opinion Leaders.